Home›Search›Exploration of Targeted Anti-tumor Therapy

Exploration of Targeted Anti-tumor Therapy

Open Exploration Publishing Inc · China · Est. 1980

ISSN2692-3114

SJR Q2✓ Scopus / SJR✓ DOAJ✓ Open Access

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 50% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.883

H-Indexi

SNIPi

0.418

Total Worksi

372

Total Citationsi

3,320

2yr Mean Citednessi

4.57

Open Impact Factor alternative

Aims & Scope

Exploration of Targeted Anti-tumor Therapy aims to publish high-quality research articles, reviews, and perspectives on targeted anti-tumor therapies. The journal covers a broad range of topics including molecular mechanisms of cancer, drug discovery and development, precision oncology, biomarkers, and clinical trials. It also welcomes submissions on emerging areas such as cancer immunotherapy, liquid biopsy, and artificial intelligence in cancer care.

General Information

Country / RegionChina

Primary LanguageEnglish

1st Year Published1980

FrequencyMonthly

StatusActive (last: 2026)

Total Publications372

OA Since2019

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

Portico

Think.Check.Submit Compliance

thinkchecksubmit.org

10/11 · 91%

✅

Do you know the journal / publisher?

Open Exploration Publishing Inc

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2692-3114

✅

Indexed in a trusted database?

Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

960

2020

387

2021

698

2022

843

2023

642

2024

455

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ2

Cancer ResearchQ3

Subject Classification

Scopus Categories

Cancer ResearchOncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsLung Cancer Treatments and MutationsCancer Cells and MetastasisLung Cancer Research StudiesImmunotherapy and Immune ResponsesHER2/EGFR in Cancer ResearchImmune cells in cancerProtein Degradation and InhibitorsPancreatic and Hepatic Oncology Research

Frequently asked questions about Exploration of Targeted Anti-tumor Therapy

Is Exploration of Targeted Anti-tumor Therapy a predatory journal?

PubScope has no integrity flags on record for Exploration of Targeted Anti-tumor Therapy: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Exploration of Targeted Anti-tumor Therapy?

Exploration of Targeted Anti-tumor Therapy is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.883.

Is Exploration of Targeted Anti-tumor Therapy indexed in Scopus and Web of Science?

Exploration of Targeted Anti-tumor Therapy is indexed in Scopus, DOAJ.